ConductScience.org, home

Gene · 3913

NIH grants2,633

NIH grants whose papers are about the gene, through NIH's grant-paper links.

1,401 to 1,420 of 2,633

Download this page as JSON
GrantTitleLAMB2 papersNewest fiscal year
R21AI130504Anti-NET autoantibodies in cystic fibrosis12018
R21AR071554Identifying gene and regulatory networks underlying postnatal tendon cell growth12018
R21CA212932High Content Screening of Multicellular Invasion with 3D Traction Force Microscopy12018
R21EB024329Decellularized Avian Lungs for Use in Pulmonary Therapeutics12018
R21ES026282Investigating modes of action of glyphosate-induced ovotoxicity12018
R21ES028124Impact of endocrine disruptors on the human sperm methylome: a risk factor for autism?12018
R21HD091717Magnetomyography of levator muscle complex in pregnancy and postpartum: Adaptation, injury, and recovery patterns12018
R33CA202820Clinical implementation of single cell tumor transcriptome analysis12018
R33CA206937Protein painting identifies therapeutic targets at protein-protein interfaces12018
R35GM127130Aptamer Engineering: From Molecule to Medicine12018
R37AR042703Molecular Physiology of Myotonia and Periodic Paralysis12018
R37HL068546Glucocorticosteroid Action In Inflammatory Disease12018
R56DE013414MATRIX BASED MINERAL ENAMEL-BIOMIMETICS12018
R61AR073042Dissecting autoimmune cellular and molecular networks in vitiligo12018
RF1AG057965ALZHEIMER'S DISEASE PATHWAYS AND BIOMARKER DISCOVERY BY INTEGRATIVE PROTEOMICS, GLYCOPROTEOMICS, AND GLYCOMICS12018
RF1AG059093Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment12018
RF1AG059319SYSTEMATIC DRUG REPURPOSING TARGETING IMMUNE ACTIVATION NETWORKS IN ALZHEIMER'S DISEASE (AD)12018
RF1MH116989A method for anterograde trans-synaptic tracing12018
S10OD023689BD FACSAria Fusion for Flow Cytometry Core Facility12018
S10OD025030Nikon A1R-ER Confocal Microscope for the Microscopy Imaging Center12018

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3913/grants?page=71